Cargando…
Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma()
Human hepatocellular carcinoma (HCC) is a malignant cancer. It is a challenge to develop anti-HCC drugs due to HCC's extreme aggressiveness and with the sensitivity of the liver to show severe adverse effects. More importantly, the precise mechanisms causing HCC pathogenicity are not known. Our...
Autores principales: | Zhu, Bo, Chen, Shaobo, Hu, Xiaoding, Jin, Xiaofeng, Le, Yichen, Cao, Lihuan, Yuan, Zhonghua, Lin, Zhen, Jiang, Songmin, Sun, Lichun, Yu, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476975/ https://www.ncbi.nlm.nih.gov/pubmed/28628795 http://dx.doi.org/10.1016/j.neo.2017.02.007 |
Ejemplares similares
-
UNC50 Prompts G1/S Transition and Proliferation in HCC by Regulation of Epidermal Growth Factor Receptor Trafficking
por: Fang, Zhou, et al.
Publicado: (2015) -
Upregulation of Nogo‐B by hypoxia inducible factor‐1 and activator protein‐1 in hepatocellular carcinoma
por: Han, Dingding, et al.
Publicado: (2021) -
Axonal regeneration after optic nerve crush in Nogo-A/B/C knockout mice
por: Su, Ying, et al.
Publicado: (2008) -
Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis
por: Teng, Felicia Yu Hsuan, et al.
Publicado: (2008) -
Nogo‐B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma
por: Cai, Hao, et al.
Publicado: (2018)